2023 clinical immunization safety assessment (cisa) base IDIQ
Active Awarded Last action
- Contract number
- 75D30123D17920
- Awardee
-
Boston Medical Center Corporation UEI JZ8RQC4EMDZ5
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 3 $2,548,724 obligated
Award facts
- Opportunity
-
- 75D30123R72838 Solicitation number
- Combined order value
-
- $2,554,850 Current, with exercised options
- $2,807,566 Potential, with all options
- Last date to order 62% complete
- IDV ceiling 3% used
- $86,008,000.12
- Maximum order
- $86,008,000.12
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention Pittsburgh awarded a multiple-award indefinite-delivery contract to Boston Medical Center Corporation for clinical immunization safety assessment services, with a ceiling of $86,008,000.12 and an award date of September 26, 2023.
This is a full-and-open, no-set-aside procurement. Place of performance is Roxbury, Massachusetts, with subordinate immunization safety assessment activities conducted through the ultimate completion date of September 21, 2028.
The CISA IDIQ was established under Executive Order 14398 to procure clinical immunization safety assessment research and services supporting the Department of Health and Human Services' immunization safety programs. The base period runs through September 21, 2028, with no separately identified options stated in the source.
Task-order activity under this IDIQ totals $4.3 million in potential value across nine delivery orders. Recent orders include a $1,091,528 cost-no-fee delivery order awarded September 28, 2023, through September 27, 2028, for clinical immunization safety research services, and a prior $912,168 cost-no-fee delivery order awarded September 28, 2023, through September 27, 2026, for immunization safety assessment services. Both orders are performed at the Roxbury, Massachusetts location.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Cisa home laiv study - contributing site EO 14398 | CDC Pittsburgh | $784,899 | |
| 2023 clinical immunization safety assessment (cisa) base IDIQ | CDC Pittsburgh | $855,741 | |
| 2023 clinical immunization safety assessment (cisa) base IDIQ | CDC Pittsburgh | $908,084 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75D30123D17920?
75D30123D17920 was awarded to Boston Medical Center Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 26, 2023.
How much is contract 75D30123D17920 worth?
Orders under 75D30123D17920 have obligated $2,548,724. Their combined current value, with exercised options, is $2,554,850. Their combined potential value, with all options, is $2,807,566. 75D30123D17920's own ceiling is $86,008,000. A single order can be worth up to $86,008,000.
How many orders have been placed under contract 75D30123D17920?
3 orders have been placed under 75D30123D17920, the latest on September 25, 2026.
Who can order from contract 75D30123D17920?
75D30123D17920 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75D30123D17920 part of a contract vehicle?
Yes. 75D30123D17920 is part of Clinical Immunization Safety Assessment 2023 - 2028 (CISA).
Was contract 75D30123D17920 competed?
The extent of competition for 75D30123D17920 was full and open competition. The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV